SNSE Shares Outstanding History

Below is a table of the SNSE shares outstanding history going back to 2/4/2021:

Date SNSE Shares Outstanding

Also see: SNSE Market Cap History
SNSE Historical Shares Outstanding:
-4.05% CAGR
SNSE Historical Shares Outstanding: +-4.05% CAGR

Mouse over chart for data details
2/4/2021 ...2/23/2024
Sensei Biotherapeutics is an immuno-oncology company focused on the discovery and development of therapeutics for cancer patients. Through its Tumor Microenvironment Activated Biologics platform, Co. is developing therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals in the tumor microenvironment. Co.'s product candidates: SNS-101, which is Co.'s monoclonal antibody targeting the immune checkpoint V-domain Ig suppressor of T-cell activation; SNS-102, which is Co.'s monoclonal antibody targeting V-Set and Immunoglobulin Domain Containing 4; and SNS-103, which is Co.'s monoclonal antibody targeting ecto-nucleoside triphosphate diphosphohydrolase-1. We show 13 historical shares outstanding datapoints in our coverage of SNSE's shares outstanding history.

Understanding the changing numbers of SNSE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SNSE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SNSE by allowing them to research SNSE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SNSE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sensei Biotherapeutics (SNSE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SNSS Shares Outstanding History
SOLY Shares Outstanding History
SONN Shares Outstanding History
SONX Shares Outstanding History
SPEX Shares Outstanding History
SPNE Shares Outstanding History
SPPI Shares Outstanding History
SPRB Shares Outstanding History
SPRO Shares Outstanding History
SPRY Shares Outstanding History
More Healthcare companies »


SNSE Shares Outstanding History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.